0001628280-22-004491 Sample Contracts

EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • March 1st, 2022 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington

This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Priti Patel (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of April 14, 2021, to be effective as of the Effective Date (as defined below).

AutoNDA by SimpleDocs
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. AMENDMENT NO. 2 TO EXCLUSIVE START- UP LICENSE...
License Agreement • March 1st, 2022 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations

This Amendment No. 2 to the Exclusive Start-Up License Agreement (this “Amendment No. 2”) effective as of December 15, 2021 (the “Amendment No. 2 Effective Date”), is entered into between the University of Washington (“University”), and Neoleukin Therapeutics, Inc. (“Company”). “Party” or “Parties” shall mean, individually, University or Company as the context requires and, collectively, both University and Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!